Resultado da Busca
Kenneth Carleton Frazier (born December 17, 1954) is an American business executive. He is executive chairman and former CEO of the pharmaceutical company Merck & Co. (known as MSD outside of North America).
12 de jun. de 2023 · Former CEO and executive chairman of Merck, Ken Frazier, offers candid reflections on how crises tested his commitment to values—both Merck’s and his own.
4 de fev. de 2021 · KENILWORTH, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that Kenneth C. Frazier, chairman and chief executive officer, will retire as CEO, effective June 30, 2021.
4 de fev. de 2021 · Merck & Co's chief executive Kenneth Frazier is retiring at the end of June, the drugs company said. The firm said he would be replaced by current chief financial officer Robert Davis, who...
4 de fev. de 2021 · Merck’s outspoken chairman and CEO, Ken Frazier, is retiring after almost 30 years at the drugmaker, the company announced Thursday.
4 de fev. de 2021 · Merck CEO Kenneth Frazier, who is currently one of the few Black CEOs of a Fortune 500 company, is retiring in June, ending a nearly 30-year run with the company.
27 de out. de 2021 · Ken Frazier. Executive chairman of the board and former CEO of Merck. This bold and determined mindset complemented with strong leadership is what led Chief Executive magazine’s CEO of the Year Selection Committee to name Ken Frazier 2021 CEO of the Year.
